Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7917778rdf:typepubmed:Citationlld:pubmed
pubmed-article:7917778lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:7917778lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:7917778lifeskim:mentionsumls-concept:C0019932lld:lifeskim
pubmed-article:7917778lifeskim:mentionsumls-concept:C0025329lld:lifeskim
pubmed-article:7917778lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:7917778pubmed:issue6lld:pubmed
pubmed-article:7917778pubmed:dateCreated1994-11-10lld:pubmed
pubmed-article:7917778pubmed:abstractText1. Up to 40% of female asthmatic subjects suffer a premenstrual deterioration in their condition which may be ameliorated by progesterone supplementation, although the mechanism responsible for this phenomenon is not understood. In vitro studies have shown that female sex-steroid hormones potentiate the bronchorelaxant effect of isoprenaline, whilst in vivo it has been shown that females exhibit greater sensitivity of systemic beta 2-adrenoceptor responses. 2. The aim of the present study was to determine whether cyclical alterations in beta 2-adrenoceptor expression, occurring under the influence of ovarian sex-steroid hormones, may offer an explanation for these findings. In vitro parameters of lymphocyte beta 2-adrenoceptor function were investigated in nine normal female subjects (aged 24 +/- 2 years) during the follicular (day 2-4) and luteal (day 21-23) phases of their menstrual cycle, and results were compared with those of nine age-matched healthy male controls studied at the same time intervals. 3. In female subjects there were significant increases in serum concentrations of oestradiol (3.3-fold) and progesterone (10.6-fold) between the follicular and luteal phases of the menstrual cycle, whereas no changes occurred in males. 4. In females during the luteal phase, the increase in sex-steroid hormones was mirrored by an increase in lymphocyte beta 2-adrenoceptor density (Bmax) and in maximal cyclic AMP response to isoprenaline (Emax), which were significantly higher than in male subjects. Mean differences (95% CI) between male and female subjects on visit 2 were 1.09 (0.49 to 1.69) fmol/10(6) cells (P = 0.001) for Bmax, and 3.42 (0.80 to 6.04) pmol/10(6) cells (P = 0.02) for Emax.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:languageenglld:pubmed
pubmed-article:7917778pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:citationSubsetIMlld:pubmed
pubmed-article:7917778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7917778pubmed:statusMEDLINElld:pubmed
pubmed-article:7917778pubmed:monthJunlld:pubmed
pubmed-article:7917778pubmed:issn0306-5251lld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:McDevittD GDGlld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:PetersJ AJAlld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:WheeldonN MNMlld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:CoutieW JWJlld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:LipworthB JBJlld:pubmed
pubmed-article:7917778pubmed:authorpubmed-author:NewnhamD MDMlld:pubmed
pubmed-article:7917778pubmed:issnTypePrintlld:pubmed
pubmed-article:7917778pubmed:volume37lld:pubmed
pubmed-article:7917778pubmed:ownerNLMlld:pubmed
pubmed-article:7917778pubmed:authorsCompleteYlld:pubmed
pubmed-article:7917778pubmed:pagination583-8lld:pubmed
pubmed-article:7917778pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:meshHeadingpubmed-meshheading:7917778-...lld:pubmed
pubmed-article:7917778pubmed:year1994lld:pubmed
pubmed-article:7917778pubmed:articleTitleInfluence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle.lld:pubmed
pubmed-article:7917778pubmed:affiliationDepartment of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee, Scotland.lld:pubmed
pubmed-article:7917778pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7917778lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7917778lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7917778lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7917778lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7917778lld:pubmed